JT-06

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameJT-06
Drug Alias NameJT06
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCXC chemokines inhibitors
TargetsCXC chemokines
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJyant Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJyant Technologies
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A